BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li W, Minohara M, Su JJ, Matsuoka T, Osoegawa M, Ishizu T, Kira J. Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population. J Neuroimmunol. 2007;184:227-231. [PMID: 17296235 DOI: 10.1016/j.jneuroim.2006.12.010] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Shamriz O, Shoenfeld Y. Infections: a double-edge sword in autoimmunity. Curr Opin Rheumatol. 2018;30:365-372. [PMID: 29847440 DOI: 10.1097/bor.0000000000000490] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Gorlé N, Bauwens E, Haesebrouck F, Smet A, Vandenbroucke RE. Helicobacter and the Potential Role in Neurological Disorders: There Is More Than Helicobacter pylori. Front Immunol 2020;11:584165. [PMID: 33633723 DOI: 10.3389/fimmu.2020.584165] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira E Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020;26:4076-93. [PMID: 32821071 DOI: 10.3748/wjg.v26.i28.4076] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014;20:613-629. [PMID: 24574735 DOI: 10.3748/wjg.v20.i3.613] [Cited by in CrossRef: 86] [Cited by in F6Publishing: 64] [Article Influence: 12.3] [Reference Citation Analysis]
5 Ojha S, Kumar B. A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis. Journal of Cellular Immunotherapy 2018;4:56-64. [DOI: 10.1016/j.jocit.2017.12.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Prasad H, Krishnaprasad M, Karnaker VK. Therapeutic induction of Helicobacter pylori bacteraemia in multiple sclerosis: How far from reality? Medical Hypotheses 2008;71:610-1. [DOI: 10.1016/j.mehy.2008.05.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Kira J. Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2015;86:591-2. [PMID: 25602010 DOI: 10.1136/jnnp-2014-309759] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter. 2008;13 Suppl 1:47-57. [PMID: 18783522 DOI: 10.1111/j.1523-5378.2008.00634.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
9 Hasni SA. Role of Helicobacter pylori infection in autoimmune diseases. Curr Opin Rheumatol. 2012;24:429-434. [PMID: 22617822 DOI: 10.1097/bor.0b013e3283542d0b] [Cited by in Crossref: 41] [Cited by in F6Publishing: 12] [Article Influence: 4.6] [Reference Citation Analysis]
10 Nowacek A, Kosloski LM, Gendelman HE. Neurodegenerative disorders and nanoformulated drug development. Nanomedicine (Lond) 2009;4:541-55. [PMID: 19572820 DOI: 10.2217/nnm.09.37] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
11 Robinson K. Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. Diseases. 2015;3:34-55. [PMID: 28943607 DOI: 10.3390/diseases3020034] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
12 Koch KN, Müller A. Helicobacter pylori activates the TLR2/NLRP3/caspase-1/IL-18 axis to induce regulatory T-cells, establish persistent infection and promote tolerance to allergens. Gut Microbes 2015;6:382-7. [PMID: 26727421 DOI: 10.1080/19490976.2015.1105427] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
13 Patrick KL, Bell SL, Weindel CG, Watson RO. Exploring the "Multiple-Hit Hypothesis" of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat. Front Cell Infect Microbiol 2019;9:138. [PMID: 31192157 DOI: 10.3389/fcimb.2019.00138] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
14 Kira J, Isobe N. Helicobacter pylori infection and demyelinating disease of the central nervous system. Journal of Neuroimmunology 2019;329:14-9. [DOI: 10.1016/j.jneuroim.2018.06.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
15 Cook KW, Crooks J, Hussain K, O'Brien K, Braitch M, Kareem H, Constantinescu CS, Robinson K, Gran B. Helicobacter pylori infection reduces disease severity in an experimental model of multiple sclerosis. Front Microbiol. 2015;6:52. [PMID: 25762984 DOI: 10.3389/fmicb.2015.00052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
16 Kira J. Genetic and environmental backgrounds responsible for the changes in the phenotype of MS in Japanese subjects. Mult Scler Relat Disord 2012;1:188-95. [PMID: 25877266 DOI: 10.1016/j.msard.2012.05.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
17 Ranjbar R, Karampoor S, Jalilian FA. The protective effect of Helicobacter Pylori infection on the susceptibility of multiple sclerosis. Journal of Neuroimmunology 2019;337:577069. [DOI: 10.1016/j.jneuroim.2019.577069] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
18 Malli C, Pandit L, D'Cunha A, Mustafa S. Environmental factors related to multiple sclerosis in Indian population. PLoS One. 2015;10:e0124064. [PMID: 25902359 DOI: 10.1371/journal.pone.0124064] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
19 Kountouras J, Zavos C, Gavalas E, Boziki M, Katsinelos P. Helicobacter pylori may hold a variable role in multiple sclerosis based on ethnicity. Medical Hypotheses 2008;71:614-5. [DOI: 10.1016/j.mehy.2008.05.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
20 Li W, Minohara M, Piao H, Matsushita T, Masaki K, Matsuoka T, Isobe N, Su JJ, Ohyagi Y, Kira J. Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica. Mult Scler. 2009;15:1411-1421. [PMID: 19965522 DOI: 10.1177/1352458509348961] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
21 Ghalamfarsa G, Hojjat-farsangi M, Mohammadnia-afrouzi M, Anvari E, Farhadi S, Yousefi M, Jadidi-niaragh F. Application of nanomedicine for crossing the blood–brain barrier: Theranostic opportunities in multiple sclerosis. Journal of Immunotoxicology 2016;13:603-19. [DOI: 10.3109/1547691x.2016.1159264] [Cited by in Crossref: 22] [Cited by in F6Publishing: 3] [Article Influence: 4.4] [Reference Citation Analysis]
22 Alvarez-Arellano L, Maldonado-Bernal C. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol. 2014;5:400-404. [PMID: 25400983 DOI: 10.4291/wjgp.v5.i4.400] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 35] [Article Influence: 6.1] [Reference Citation Analysis]
23 Deretzi G, Gavalas E, Boziki M, Tsiptsios D, Polyzos SA, Venizelos I, Zavos C, Koutlas E, Tsiptsios I, Katsinelos P, Kountouras J. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurol Scand 2016;133:268-75. [DOI: 10.1111/ane.12453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
24 Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Rigopoulou EI, Scheper T, Daponte A, Meyer W, Sakkas LI, Hadjigeorgiou G, Bogdanos DP. Immune responses against Helicobacter pylori-specific antigens differentiate relapsing remitting from secondary progressive multiple sclerosis. Sci Rep. 2017;7:7929. [PMID: 28801580 DOI: 10.1038/s41598-017-07801-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
25 Duckworth MJ, Okoli AS, Mendz GL. Novel Helicobacter pylori therapeutic targets: the unusual suspects. Expert Rev Anti Infect Ther 2009;7:835-67. [PMID: 19735225 DOI: 10.1586/eri.09.61] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
26 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Pedrini MJ, Seewann A, Bennett KA, Wood AJ, James I, Burton J, Marshall BJ, Carroll WM, Kermode AG. Helicobacter pylori infection as a protective factor against multiple sclerosis risk in females. J Neurol Neurosurg Psychiatry. 2015;86:603-607. [PMID: 25602009 DOI: 10.1136/jnnp-2014-309495] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
28 Salvucci E. Microbiome, holobiont and the net of life. Crit Rev Microbiol 2016;42:485-94. [PMID: 25430522 DOI: 10.3109/1040841X.2014.962478] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
29 Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013;18 Suppl 1:44-51. [PMID: 24011245 DOI: 10.1111/hel.12077] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 7.9] [Reference Citation Analysis]
30 Mohebi N, Mamarabadi M, Moghaddasi M. Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients. Neurol Int. 2013;5:31-33. [PMID: 23888213 DOI: 10.4081/ni.2013.e10] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
31 Kira J. Genetic and environmental factors underlying the rapid changes in epidemiological and clinical features of multiple sclerosis and neuromyelitis optica in Japanese. Clin Exp Neuroimmunol 2013;4:261-73. [DOI: 10.1111/cen3.12034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
32 Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, Ochi H, Kira J. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. PLoS One 2014;9:e95367. [PMID: 24736746 DOI: 10.1371/journal.pone.0095367] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
33 Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol. 2008;86:175-178. [PMID: 17923849 DOI: 10.1038/sj.icb.7100119] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
34 Efthymiou G, Dardiotis E, Liaskos C, Marou E, Tsimourtou V, Scheper T, Meyer W, Daponte A, Sakkas LI, Hadjigeorgiou G. Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis. J Neuroimmunol. 2016;298:19-23. [PMID: 27609271 DOI: 10.1016/j.jneuroim.2016.06.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
35 Pezeshki MZ, Zarrintan S, Zarrintan MH. Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis. Med Hypotheses. 2008;70:1223. [PMID: 18242004 DOI: 10.1016/j.mehy.2007.12.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Oertli M, Sundquist M, Hitzler I, Engler DB, Arnold IC, Reuter S, Maxeiner J, Hansson M, Taube C, Quiding-Järbrink M. DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. J Clin Invest. 2012;122:1082-1096. [PMID: 22307326 DOI: 10.1172/jci61029] [Cited by in Crossref: 185] [Cited by in F6Publishing: 113] [Article Influence: 20.6] [Reference Citation Analysis]
37 Kountouras J, Gavalas E, Deretzi G, Boziki M, Zavos C, Chatzopoulos D, Katsinelos P, Giartza-Taxidou E, Grigoriadis N, Venizelos I. Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica. Mult Scler. 2010;16:376-377; author reply 378-379. [PMID: 20203152 DOI: 10.1177/1352458509360550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
38 Yuan F, Thiele GM, Wang D. Nanomedicine development for autoimmune diseases. Drug Dev Res 2011;72:703-16. [DOI: 10.1002/ddr.20479] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
39 Kountouras J, Deretzi G, Gavalas E, Zavos C, Boziki M, Tsiaousi E, Stergiopoulos C, Romiopoulos I, Giorgakis N, Michael S, Tantsi N, Kotsani M. Aquaporin 4, Helicobacter pylori and potential implications for neuromyelitis optica. Journal of Neuroimmunology 2013;263:162-3. [DOI: 10.1016/j.jneuroim.2013.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
40 Kountouras J, Papaefthymiou A, Gavalas E, Polyzos SA, Boziki M, Kyriakou P, Katsinelos P, Zavos C, Liatsos C, Tzivras D, Tzitiridou-chatzopoulou M, Dardiotis E, Deretzi G, Vardaka E, Doulberis M. Helicobacter pylori infection as a potential risk factor for multiple sclerosis. Medical Hypotheses 2020;143:110135. [DOI: 10.1016/j.mehy.2020.110135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Gavalas E, Kountouras J, Deretzi G, Boziki M, Grigoriadis N, Zavos C, Venizelos I. Helicobacter pylori and multiple sclerosis. J Neuroimmunol. 2007;188:187-189; author reply 190. [PMID: 17614142 DOI: 10.1016/j.jneuroim.2007.06.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
42 Robinson K, Stephens J, Constantinescu CS, Gran B. Helicobacter pylori, Experimental Autoimmune Encephalomyelitis, and Multiple Sclerosis. In: Constantinescu C, Arsenescu R, Arsenescu V, editors. Neuro-Immuno-Gastroenterology. Cham: Springer International Publishing; 2016. pp. 97-122. [DOI: 10.1007/978-3-319-28609-9_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
43 Yao G, Wang P, Luo XD, Yu TM, Harris RA, Zhang XM. Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis. Neurosci Lett. 2016;620:1-7. [PMID: 27033666 DOI: 10.1016/j.neulet.2016.03.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
44 Sakoda A, Matsushita T, Nakamura Y, Watanabe M, Shinoda K, Masaki K, Isobe N, Yamasaki R, Kira JI. Environmental risk factors for multiple sclerosis in Japanese people. Mult Scler Relat Disord 2020;38:101872. [PMID: 31812038 DOI: 10.1016/j.msard.2019.101872] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
45 Hussain K, Letley DP, Greenaway AB, Kenefeck R, Winter JA, Tomlinson W, Rhead J, Staples E, Kaneko K, Atherton JC. Helicobacter pylori-Mediated Protection from Allergy Is Associated with IL-10-Secreting Peripheral Blood Regulatory T Cells. Front Immunol. 2016;7:71. [PMID: 27014260 DOI: 10.3389/fimmu.2016.00071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
46 Park AM, Omura S, Fujita M, Sato F, Tsunoda I. Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies. Clin Exp Neuroimmunol 2017;8:215-32. [PMID: 29158778 DOI: 10.1111/cen3.12401] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
47 Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World J Gastroenterol. 2014;20:12781-12808. [PMID: 25278678 DOI: 10.3748/wjg.v20.i36.12781] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 114] [Article Influence: 23.0] [Reference Citation Analysis]
48 Arnold IC, Hitzler I, Müller A. The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders. Front Cell Infect Microbiol. 2012;2:10. [PMID: 22919602 DOI: 10.3389/fcimb.2012.00010] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 8.1] [Reference Citation Analysis]
49 Rojas M, Restrepo-jiménez P, Monsalve DM, Pacheco Y, Acosta-ampudia Y, Ramírez-santana C, Leung PS, Ansari AA, Gershwin ME, Anaya J. Molecular mimicry and autoimmunity. Journal of Autoimmunity 2018;95:100-23. [DOI: 10.1016/j.jaut.2018.10.012] [Cited by in Crossref: 112] [Cited by in F6Publishing: 81] [Article Influence: 37.3] [Reference Citation Analysis]